UniCredit Bank GmbH Stock

Certificat

DE000HVB80M1

Market Closed - Deutsche Boerse AG 01:28:11 2024-06-06 pm EDT
89.41 EUR -1.02% Intraday chart for UniCredit Bank GmbH
Current month+1.52%
1 month+2.23%
Date Price Change
24-06-06 89.41 -1.02%
24-06-05 90.33 -0.21%
24-06-04 90.52 +0.82%
24-06-03 89.78 +1.94%
24-05-31 88.07 +0.51%

Delayed Quote Deutsche Boerse AG

Last update June 06, 2024 at 01:28 pm EDT

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HVB80M
ISINDE000HVB80M1
Date issued 2023-08-01
Strike 36.07 $
Maturity 2026-07-27 (781 Days)
Parity 0.04 : 1
Emission price 100
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 101
Lowest since issue 80.66
Spread 9
Spread %1.00%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.8 USD
Average target price
31.92 USD
Spread / Average Target
+10.82%
Consensus